AI-Assisted Line-Field Confocal Optical Coherence Tomography for Early Detection of Subclinical Basal Cell Carcinoma: Current Evidence and Clinical Prospects

MedXY Editorial Team•Aug 26, 2026•Clinical Updates

Basal cell carcinoma (BCC) is the most frequent skin cancer, with early detection critical to reduce morbidity from facial lesions.
Line-field confocal optical coherence tomography (LC-OCT) provides high-resolution, noninvasive imaging of skin architecture, enabling detection beyond visible lesions.
Artificial intelligence (AI) integration with LC-OCT enhances diagnostic accuracy for subclinical BCC in high-risk populations, with positive predictive values up to 94.4%.
Subtype classification of BCC via AI-assisted LC-OCT shows promising accuracy, aiding tailored clinical management.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.